Alluvi BPC-157 & TB-500 40mg – Advanced Research Peptide Blend
Alluvi BPC-157 & TB-500 40mg is a dual-peptide research formulation intended for controlled laboratory investigations into cellular signaling, tissue biology, and experimental peptide interactions.
Combining two widely studied investigational peptides, BPC-157 and TB-500, this formulation is relevant to scientific research exploring cellular responses, tissue-associated signaling pathways, and peptide-related biological mechanisms.
BPC-157 is a synthetic peptide consisting of 15 amino acids, while TB-500 is commonly associated with research involving thymosin beta-4-related peptide sequences. Both compounds have attracted scientific interest in preclinical investigations of tissue biology and cellular function.
Key Features
- 40mg Research Blend: Labeled total peptide content of 40mg per formulation.
- Dual-Peptide Combination: Contains BPC-157 and TB-500 for laboratory investigation.
- Cellular Research: Relevant to experimental studies examining cellular signaling and biological responses.
- Tissue Biology Research: Supports investigations into experimental tissue-associated mechanisms.
- Research Applications: Intended for controlled laboratory experimentation by qualified professionals.
Research Applications
The BPC-157 and TB-500 combination is of interest in several areas of preclinical research, including:
- Cellular migration and signaling pathways
- Experimental tissue-response mechanisms
- Angiogenesis-related signaling research
- Peptide interactions in biological models
- Extracellular matrix and cellular organization
- Preclinical investigations of tissue repair mechanisms
Understanding BPC-157 and TB-500
BPC-157 – Experimental Cellular Research
BPC-157 is a synthetic pentadecapeptide studied primarily in preclinical experimental models. Researchers have investigated its potential interactions with biological pathways associated with cellular signaling, tissue responses, and vascular processes.
Although preliminary findings have generated scientific interest, reliable clinical evidence establishing its safety and effectiveness in humans remains insufficient.
TB-500 – Thymosin Beta-4-Related Research
TB-500 is a name used for synthetic peptides associated with thymosin beta-4 research. The precise peptide sequence may vary between products marketed under this name. Alluvi healthcare
Thymosin beta-4-related research has examined actin regulation, cell migration, and tissue-associated biological processes. Findings involving full-length thymosin beta-4 should not automatically be attributed to every TB-500 formulation.
Product Specifications
- Product Name: Alluvi BPC-157 & TB-500 40mg
- Brand: Alluvi
- Compound Type: Synthetic Research Peptide Blend
- Labeled Total Quantity: 40mg
- Research Components: BPC-157 and TB-500
- Product Category: Research Peptides
- Intended Application: Laboratory Research Only
Important Research Disclaimer
Alluvi BPC-157 & TB-500 40mg is intended strictly for laboratory research purposes only.
This product is not intended for human consumption, injection, veterinary administration, self-medication, or therapeutic use.
BPC-157 and TB-500 are investigational compounds. Their safety and effectiveness for treating injuries, accelerating recovery, or managing medical conditions have not been established through adequate human clinical studies.
All research should be conducted by qualified professionals following applicable laboratory safety procedures and regulations.
